Discover 382 paid clinical trials in Chesapeake, Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 382
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
for
Multiple Myeloma
Location: Norfolk VA, Richmond VA, Fort Belvoir VA, Durham NC,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT05552222
Phase 3, Recruiting
Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases
for
Carcinoma, Non-Small-Cell Lung Cancer,
Location: Norfolk VA, Pittsburgh PA, Tyler TX, Beverly Hills CA
Sponsor: Kiromic BioPharma Inc.
Sex: All
Age: 18+
Code: NCT06069570
Phase 1, Recruiting
Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors
for
Solid Tumor
Location: Norfolk VA, Philadelphia PA, Pittsburgh PA, Edgewood KY,
Sponsor: ImmunoGenesis
Sex: All
Age: 18+
Code: NCT06014502
Phase 1, Recruiting
Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
for
Breast Cancer
Location: Norfolk VA, Columbia MD, Salem VA, Bensalem PA,
Sponsor: SCRI Development Innovations, LLC
Sex: All
Age: 18+
Code: NCT05748834
Phase 2, Recruiting
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Location: Norfolk VA, Charlottesville VA, Fairfax VA,
Sponsor: Sumitomo Pharma America, Inc.
Sex: All
Age: 12+
Code: NCT04988555
Phase 1, Phase 2, Recruiting
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Norfolk VA, Chapel Hill NC, Philadelphia PA,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06297226
Phase 2, Recruiting
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation
for
Non-Small Cell Lung Cancer
Location: Norfolk VA, Blacksburg VA, New York NY, Mineola NY,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT05789082
Phase 1, Phase 2, Recruiting
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
for
Metastatic HER2-positive Breast Cancer
Location: Norfolk VA, Washington D.C. DC, Fairfax VA,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06435429
Phase 3, Recruiting
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
for
Large B-cell Lymphoma
Location: Norfolk VA, Charlottesville VA, Washington D.C. DC,
Sponsor: Allogene Therapeutics
Sex: All
Age: 18+
Code: NCT06500273
Phase 2, Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Location: Norfolk VA, Baltimore MD, East Brunswick NJ,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07218380
Phase 3, Recruiting
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
for
HR+/HER2- Breast Cancer
Location: Norfolk VA, Richmond VA, Wilson NC, Charlottesville VA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07492641
Phase 3, Recruiting
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Location: Norfolk VA, Durham NC, Philadelphia PA, Pittsburgh PA,
Sponsor: Amgen
Sex: Male
Age: 18+
Code: NCT07493512
Phase 1, Recruiting
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Norfolk VA, Fairfax VA, Rockville MD, Myrtle Beach SC,
Sponsor: BioNTech SE
Sex: Male
Age: 18+
Code: NCT07365995
Phase 3, Recruiting
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer